Here Are Wednesday's Best Wall Street Analyst Research Calls: Block, Charles River Laboratories, Cognizant Technology, Constellation Energy, Credicorp, First Solar, GE Vernova, Huntsman, Macerich, and More

Futures are trading mixed as we hit the midweek point, as the Space Exploration Technologies (NASDAQ: SPCX) or SpaceX IPO rush is starting to fade somewhat.

24/7 Wall Street • Jun 17, 2026

Omega Healthcare: Still A Great Company, But No Longer The Bargain It Was

Omega Healthcare Investors is downgraded from bullish to neutral as valuation now reflects its recovery and growth prospects. OHI's dividend is well covered, with payout ratios at 82% of AFFO and 86% of FAD, and management hints at a possible raise in 2027. Active portfolio management, capital recycling, and a strategic pivot toward RIDEA and senior housing are driving operational improvements and future growth potential.

Seeking Alpha • Jun 17, 2026

PINE or OHI: Which Is the Better Value Stock Right Now?

Investors looking for stocks in the REIT and Equity Trust - Other sector might want to consider either Alpine Income (PINE) or Omega Healthcare Investors (OHI). But which of these two stocks offers value investors a better bang for their buck right now?

Zacks Investment Research • Jun 11, 2026

Omega Healthcare Investors: High Yield, Improving Fundamentals, Attractive Price

Omega Healthcare Investors offers a compelling high-yield opportunity after a recent price pullback, now yielding over 6%. OHI's fundamentals are robust, with FAD per share up 9.5% YoY, improved dividend coverage at 86%, and tenant rent coverage at a decade high. Strategic expansion into RIDEA structures and value-added acquisitions positions OHI for potentially strong total returns.

Seeking Alpha • Jun 5, 2026

PINE vs. OHI: Which Stock Is the Better Value Option?

Investors interested in stocks from the REIT and Equity Trust - Other sector have probably already heard of Alpine Income (PINE) and Omega Healthcare Investors (OHI). But which of these two stocks is more attractive to value investors?

Zacks Investment Research • May 26, 2026

Omega Announces Its Planned Leadership Transition

HUNT VALLEY, Md.--(BUSINESS WIRE)---- $OHI #Healthcare--Omega Healthcare Investors, Inc. (NYSE: OHI) (the “Company” or “Omega”) today announced that Matthew Gourmand, President of Omega, will become the Company's Chief Executive Officer in conjunction with the planned retirement of Taylor Pickett effective October 1, 2026. Mr. Pickett will step down from the Board of Directors upon his retirement, and the Board of Directors intends to appoint Mr. Gourmand to the Board, effective on that date. Omega also announced t.

Business Wire • May 21, 2026

Omega Healthcare's Dividend Looks Stable — Operator Pressure Is The Variable

BLUF: Omega Healthcare Investors (NYSE:OHI) maintained its $0.67 quarterly dividend in Q1 2026, with cash flow comfortably covering the payout. The structural question is whether operator-level pressure at Maplewood and Genesis stays contained — or migrates into the broader portfolio.

Benzinga • May 6, 2026

SRET's Monthly Payouts Survive Global Real Estate Stress, Data Shows

Global X SuperDividend REIT ETF (NYSEARCA:SRET) holds roughly 30 of the highest-yielding REITs worldwide, equally weighted, with monthly distributions.

24/7 Wall Street • May 6, 2026

REITs Excel, Earnings Swell, Fed Rebels

U.S. equity markets advanced for a fifth straight week - their longest winning streak since 2024 - as strong earnings, resilient data, and hopes for lasting Iran peace fueled optimism. Investors looked through another oil-price surge and inflationary pressure, focusing instead on corporate resilience and economic strength despite a complex macro backdrop shaped by geopolitical and policy uncertainty. The Fed held rates steady in an unusually fractured 8-4 vote, while Powell's plan to remain on the Board broke precedent and raised politically charged succession questions.

Seeking Alpha • May 3, 2026

Omega Healthcare Investors: A High-Yield Play On The Silver Tsunami With RIDEA Upside

Omega Healthcare Investors is rated Buy, with strong long-term potential and a valuation reflecting elevated risk. OHI delivered a solid Q1, raised 2026 AFFO guidance to $3.19–$3.25 per share, and advanced its SHOP/RIDEA operational pivot. Risks include macro headwinds from the Iran conflict, higher rates, tenant pressures, and increased operational exposure from the SHOP model.

Seeking Alpha • Apr 29, 2026